Skip to Content

WATSON 493 250 mg (Mexiletine hydrochloride 250 mg)

Pill imprint WATSON 493 250 mg has been identified as Mexiletine hydrochloride 250 mg.

Mexiletine is used in the treatment of ventricular tachycardia; myotonia congenita; diabetic peripheral neuropathy; arrhythmia and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy. Mexiletine 250 mg is not a controlled substance under the Controlled Substance Act (CSA).

Mexiletine hydrochloride
Imprint:
WATSON 493 250 mg
Strength:
250 mg
Color:
Brown / Green
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Group I antiarrhythmics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
Watson Laboratories, Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide